Tag: Artemis 2
Top News
Unlocking Cancer Treatment: How TXN12923 Targets ULK1 for Enhanced Drug Sensitivity
Txinno Bioscience to present TXN12923, a novel ULK1 targeted protein degrader, at AACR, aiming to enhance cancer treatment efficacy.
- Our Sponsors Ad -